Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared a post on LinkedIn:
“Excited and honored to be part of the Annual Congress of European Society for Radiotherapy and Oncology (ESTRO) –in Stockholm.
Today marks the opening of one of the most important international meetings in radiation oncology, taking place from 15–19 May 2026
Very happy to meet so many national and international colleagues, friends, radiation oncologists, medical physicists, RTTs, and researchers from all around the world.
Impressive scientific program:
231 scientific sessions
1210 international speakers
2460 posters
Looking forward to inspiring discussions, new collaborations, innovation, and the future of radiation oncology and interventional radiotherapy.”
Other articles about European Society for Radiotherapy and Oncology (ESTRO) on OncoDaily.
